The New AI Gene Editing Revolution
History, Breakthroughs, and the Future of Human Medicine
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Audible Standard 30-day free trial
Select 1 audiobook a month from our entire collection of titles.
Yours as long as you’re a member.
Get unlimited access to bingeable podcasts.
Standard auto renews for $8.99 a month after 30 days. Cancel anytime.
The New AI Gene Editing Revolution
Narrated by:
Virtual Voice
Buy for $13.00
-
Narrated by:
-
Virtual Voice
-
By:
-
Richard Murch
This title uses virtual voice narration
Virtual voice is computer-generated narration for audiobooks.
In the summer of 2012, a paper appeared in the journal Science that would, within a few years, transform medicine, agriculture, and the basic life sciences more profoundly than any single publication since Watson and Crick's description of the double helix.
Its authors were Jennifer Doudna of the University of California, Berkeley, and Emmanuelle Charpentier, then at the University of Vienna. Their paper described a system -- CRISPR-Cas9 -- that could be programmed to find and cut virtually any sequence of DNA with a precision, simplicity, and affordability that made all previous gene editing tools look cumbersome by comparison.
Within a decade, Doudna and Charpentier would receive the Nobel Prize in Chemistry. Within another decade, the technology they described would be approved as a medicine for human patients.
The implications were breathtaking to any scientist who understood what earlier gene editing approaches had required. Designing a zinc finger nuclease to cut at a new location required weeks or months of protein engineering and could cost tens of thousands of dollars.
Designing a new CRISPR guide RNA required synthesizing a strand of RNA roughly twenty nucleotides long -- a process that took days and cost a few hundred dollars at most. The technology was not just more precise and reliable than its predecessors; it was orders of magnitude more accessible. Virtually any molecular biology laboratory in the world could, within weeks of reading the 2022 paper, begin working with CRISPR.
No reviews yet